Insights into the fate of the N-terminal amyloidogenic polypeptide of ApoA-I in cultured target cells

Journal of Cellular and Molecular Medicine

Volumn 15, Issue 12, 2011, Pages 2652-2663

  Arciello, Angela ^a,b   De Marco, Nadia ^a   Del Giudice, Rita ^a   Guglielmi, Fulvio ^a   Pucci, Piero ^a,c   Relini, Annalisa ^b,d   Monti, Daria Maria ^a,b   Piccoli, Renata ^a,b  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b NATIONAL INSTITUTE OF BIOSTRUCTURES AND BIOSYSTEMS   (Italy)

^c CEINGE BIOTECNOLOGIE AVANZATE   (Italy)

^d UNIVERSITY OF GENOA   (Italy)

Author keywords

Amyloidosis; Apolipoprotein A I; Binding; Cardiomyoblasts; Internalization

Indexed keywords

AMYLOID; APOLIPOPROTEIN A1; LIPID;

ANIMAL; ANIMAL EMBRYO; ARTICLE; ATOMIC FORCE MICROSCOPY; CELL CULTURE; CELL MEMBRANE; CYTOLOGY; ENDOCYTOSIS; FLUORESCENCE; HUMAN; LIVER CELL CARCINOMA; LIVER TUMOR; METABOLISM; MYOBLAST; PATHOLOGY; PHYSIOLOGY; RAT; WESTERN BLOTTING;

AMYLOID; ANIMALS; APOLIPOPROTEIN A-I; BLOTTING, WESTERN; CARCINOMA, HEPATOCELLULAR; CELL MEMBRANE; CELLS, CULTURED; EMBRYO, MAMMALIAN; ENDOCYTOSIS; FLUORESCENCE; HUMANS; LIPIDS; LIVER NEOPLASMS; MICROSCOPY, ATOMIC FORCE; MYOBLASTS, CARDIAC; RATS;

EID: 82455184941     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1582-4934.2011.01271.x     Document Type: Article

References (36)

1. Obici L, Franceschini G, Calabresi L, et al. Structure, function and amyloidogenic propensity of apolipoprotein A-I. Amyloid. 2006; 13: 1-15.
2. Gordon DJ, Rifkind BM. High-density lipoprotein-the clinical implications of recent studies. N Engl J Med. 1989; 321: 1311-6.
3. Cavelier C, Lorenzi I, Rohrer L, et al. Lipid efflux by the ATP-binding cassette transporters ABCA1 and ABCG1. Biochim Biophys Acta. 2006; 1761: 655-66.
4. Denis M, Landry YD, Zha X. ATP-binding cassette A1-mediated lipidation of apolipoprotein A-I occurs at the plasma membrane and not in the endocytic compartments. J Biol Chem. 2008; 283: 16178-86.
5. Azuma Y, Takada M, Shin HW, et al. Retroendocytosis pathway of ABCA1/apoA-I contributes to HDL formation. Genes to Cells. 2009; 14: 191-204.
6. Mukherjee S, Zha X, Tabas I, et al. Cholesterol distribution in living cells: fluorescence imaging using dehydroergosterol as a fluorescent cholesterol analog. Biophys J. 1998; 75: 1915-25.
7. Chroni A, Liu T, Fitzgerald ML, et al. Cross-linking and lipid efflux properties of apoA-I mutants suggest direct association between apoA-I helices and ABCA1. Biochemistry. 2004; 43: 2126-39.
8. Chiti F, Dobson CM. Protein misfolding, functional amyloid, and human disease. Annu Rev Biochem. 2006; 75: 333-66.
9. Eckman CB, Eckman EA. An update on the amyloid hypothesis. Neurol Clin. 2007; 25: 669-82.
10. 174→Ser causes chardiac amyloidosis, and the fibrils are constituted by the 93-residue N-terminal polypeptide. Am J Pathol. 1999; 155: 695-702.
11. Eriksson M, Schönland S, Yumlu S, et al. Hereditary apolipoprotein AI-associated amyloidosis in surgical pathology specimens: identification of three novel mutations in the APOA1 gene. J Mol Diagn. 2009; 11: 257-62.
12. Andreola A, Bellotti V, Giorgetti S, et al. Conformational switching and fibrillogenesis in the amyloidogenic fragment of apolipoprotein A-I. J Biol Chem. 2003; 278: 2444-51.
13. Di Gaetano S, Guglielmi F, Arciello A, et al. Recombinant amyloidogenic domain of ApoA-I: analysis of its fibrillogenic potential. Biochem Biophys Res Commun. 2006; 351: 223-8.
14. Tanaka M, Dhanasekaran P, Nguyen D, et al. Contributions of the N- and C-terminal helical segments to the lipid-free structure and lipid interaction of apolipoprotein A-I. Biochemistry. 2006; 45: 10351-8.
15. Monti DM, Guglielmi F, Monti M, et al. Effects of a lipid environment on the fibrillogenic pathway of the N-terminal polypeptide of human apolipoprotein A-I, responsible forin vivoamyloid fibril formation. Eur Biophys J. 2010; 39: 1289-99.
16. Campioni S, Mannini B, Zampagni M, et al. A causative link between the structure of aberrant protein oligomers and their toxicity. Nat Chem Biol. 2010; 6: 140-7.
17. Sönnichsen B, De Renzis S, Nielsen E, et al. Distinct membrane domains on endosomes in the recycling pathway visualized by multicolor imaging of Rab4, Rab5, and Rab11. J Cell Biol. 2000; 149: 901-14.
18. Rink J, Ghigo E, Kalaidzidis Y, et al. Rab conversion as a mechanism of progression from early to late endosomes. Cell. 2005; 122: 735-49.
19. Gharibyan AL, Zamotin V, Yanamandra K, et al. Lysozyme amyloid oligomers and fibrils induce cellular deathviadifferent apoptotic/necrotic pathways. J Mol Biol. 2007; 365: 1337-49.
20. Zha X, Genest J Jr, McPherson R. Endocytosis is enhanced in Tangier fibroblasts: possible role of ATP-binding cassette protein A1 in endosomal vesicular transport. J Biol Chem. 2001; 276: 39476-83.
21. Fitzgerald ML, Mendez AJ, Moore KJ, et al. ATP-binding cassette transporter A1 contains an NH2-terminal signal anchor sequence that translocates the protein's first hydrophilic domain to the exoplasmic space. J Biol Chem. 2001; 276: 15137-45.
22. Orsó E, Broccardo C, Kaminski WE, et al. Transport of lipids from golgi to plasma membrane is defective in tangier disease patients and Abc1-deficient mice. Nat Genet. 2000; 24: 192-6.
23. Neufeld EB, Stonik JA, Demosky SJ Jr, et al. The ABCA1 transporter modulates late endocytic trafficking: insights from the correction of the genetic defect in Tangier disease. J Biol Chem. 2004; 279: 15571-8.
24. Neufeld EB, Remaley AT, Demosky SJ, et al. Cellular localization and trafficking of the human ABCA1 transporter. J Biol Chem. 2001; 276: 27584-90.
25. Vedhachalam C, Ghering AB, Davidson WS, et al. ABCA1-induced cell surface binding sites for ApoA-I. Arterioscler Thromb Vasc Biol. 2007; 27: 1603-9.
26. Raimondi S, Guglielmi F, Giorgetti S, et al. Effects of the known pathogenic mutations on the aggregation pathway of the amyloidogenic peptide of Apolipoprotein A-I. J Mol Biol. 2011; doi:
27. Barbaras R, Collet X, Chap H, et al. Specific binding of free apolipoprotein A-I to a high-affinity binding site on HepG2 cells: characterization of two high-density lipoprotein sites. Biochemistry. 1994; 33: 2335-40.
28. Rohrer L, Cavelier C, Fuchs S, et al. Binding, internalization and transport of apolipoprotein A-I by vascular endothelial cells. Biochim Biophys Acta. 2006; 1761: 186-94.
29. Georgeaud V, Garcia A, Cachot D, et al. Identification of an ApoA-I ligand domain that interacts with high-affinity binding sites on HepG2 cells. Biochem Biophys Res Commun. 2000; 267: 541-5.
30. Vedhachalam C, Duong PT, Nickel M, et al. Mechanism of ATP-binding cassette transporter A1-mediated cellular lipid efflux to apolipoprotein A-I and formation of high density lipoprotein particles. J Biol Chem. 2007; 282: 25123-30.
31. Gaus K, Kritharides L, Schmitz G, et al. Apolipoprotein A-1 interaction with plasma membrane lipid rafts controls cholesterol export from macrophages. FASEB J. 2004; 18: 574-6.
32. Luzio JP, Pryor PR, Bright NA. Lysosomes: fusion and function. Nat Rev Mol Cell Biol. 2007; 8: 622-32.
33. Oram JF. The ins and outs of ABCA. J Lipid Res. 2008; 49: 1150-1.
34. Chen W, Sun Y, Welch C, et al. Preferential ATP-binding cassette transporter A1-mediated cholesterol efflux from late endosomes/lysosomes. J Biol Chem. 2001; 276: 43564-9.
35. Chen W, Wang N, Tall AR. A PEST deletion mutant of ABCA1 shows impaired internalization and defective cholesterol efflux from late endosomes. J Biol Chem. 2005; 280: 29277-81.
36. Carulla N, Caddy GL, Hall DR, et al. Molecular recycling within amyloid fibrils. Nature. 2005; 436: 554-8.